Filament Health Corp. (NEO: FH) ("Filament" or the "Company"), a clinical?stage natural psychedelic drug development company, today announced positive data from an open-label phase 2 clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback